Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.
Ronald T. Ackermann, MD, MPH
Advertisement
Articles by Ronald T. Ackermann, MD, MPH
Adults with type 2 diabetes who received nonsulfonylurea medications had relative increases in total costs. Receiving newer medication classes led to relatively decreased medical costs.
Evaluation of healthcare utilization and costs over 3 years for adults with insulin-requiring diabetes who transition from multiple daily insulin injections to insulin infusion pumps.
Over 10 years, among adherent participants, lifestyle intervention and metformin were effective and cost-effective for diabetes prevention compared with placebo.
Advertisement
Latest Updated Articles
- Costs for Commercially Insured Adults Prescribed Second-line Diabetes Medications
Published: March 9th 2021 | Updated:
Treatment Modification After Initiating Second-Line Medication for Type 2 DiabetesPublished: December 12th 2023 | Updated:
- Comparative Effectiveness and Costs of Insulin Pump Therapy for Diabetes
Published: June 21st 2017 | Updated:
- Effectiveness and Cost-Effectiveness of Diabetes Prevention Among Adherent Participants
Published: March 13th 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Rural-Urban Disparities in Colorectal Cancer Screening Persist
2
Medicaid Work Rules Could Strain Hospitals: Laxmi Patel
3
Insurance Coverage Improves for Same-Sex Couples, Yet Disparities Persist
4
Identifying Barriers to Colorectal Cancer Screening for People With IDD
5
